U.S., March 26 -- An application to own the trademark for 'OMCLISVI' has been filed on Nov. 06, 2023.
Owner(s):
Ideaya Biosciences, Inc.; 7000 Shoreline Ct, Suite 350, , CALIFORNIA
Goods and/or Services:
For: Pharmaceutical and biological preparations, namely, an orally administered protein kinase C (PKC) inhibitor for treating cancer, tumors, melanoma, and carcinoma; pharmaceutical and biological preparations for use in oncology for medical treatment purposes; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing cancer, tumors, melanoma, and carcinoma; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing metastatic uveal melanoma, primary uveal melanoma, an...